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Abstract
Background: The increasing number of patients with cardiac implantable electronic devices 
(CIEDs) causes a rise in the absolute percentage of individuals qualifying for a transvenous 
lead extraction (TLE) due to infectious, vascular or lead failure related indications. As the  
survival time prolongs, TLE procedures more and more often concern the electrodes of long-
-term functioning. Authors provide a retrospective analysis of the effectiveness and safety of 
TLE performed on leads implanted at least 10 years before the extraction.
Methods: Between 2008 and 2012 we performed TLE of 364 electrodes in 217 patients. Out 
of these, 66 (18.1%) leads in 43 (19.8%) patients had been implanted for at least 10 years. The 
mean dwelling time for electrodes was 161 months (120 to 330). In 62% of cases CIED-related 
infection was an indication for TLE. The following extracting techniques were used: manual 
direct traction, device traction, mechanical telescopic sheaths, autorotational cutting sheaths 
and femoral approach.
Results: Fifty-eight pacemakers and 8 defibrillating leads were extracted. Sixty-three (95%) 
completely, in the remaining 3 cases the clinical success was achieved with the small portion of 
the lead left into the vascular space. No major procedure complications were observed; minor 
complications were found in 3 (6%) patients.
Conclusions: TLE with the use of various endovascular techniques is an effective and safe 
method for treating infectious, vascular and mechanical complications of long-lasting CIEDs 
therapy. (Cardiol J 2014; 21, 4: 419–424)
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Introduction
The increasing number of patients with car-
diac implantable electronic devices (CIEDs) is 
a challenge in terms of organizing a professional 
health care system for this group. With the prolong-
ing survival period and an increasing number of 
multi-lead system (e.g. cardiac resynchronization 
therapy), the absolute percentage of complications 
rises. Some of these complications constitute an 
indication for transvenous lead extraction (TLE). 
The CIED-related infections require complete 
device removal. The lead-only removal should be 
considered in patients with central venous occlu-
sion, in patients with damaged leads with an indica-
tion for lead exchange, in patients with lead excess 
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(> 4) and in patients who need system upgrade 
with regaining the venous access. The expanding 
TLE techniques are more and more often used 
for treating complications of long-lasting CIEDs 
therapy. The aim of the study was a retrospective 
analysis of the effectiveness and safety of TLE 
procedures concerning the leads implanted for at 
least 10 years.
Methods
Between 2008 and 2012 we performed TLE 
of 364 electrodes in 217 patients. Out of this 
66 (18.1%) leads in 43 (19.8%) patients had been 
implanted for at least 10 years. The clinical data of 
patients were extracted from the subsequent TLE 
procedures database according to aforementioned 
criteria. The clinical characteristics of the study 
group are presented in Table 1.
The characteristics of the leads implanted at 
least 120 months before the TLE procedure were 
as follows: 58 pacing leads (9 active- and 49 pas-
sive-fixation), 8 defibrillating leads — 7 endocardial 
(5 single-coil and 2 dual-coil leads; 2 active- and 
5 passive-fixation) and 1 “floating” defibrillation 
lead placed in the superior vena cava.
The indications for TLE were: pocket infection 
in 24 (56%) patients, lead excess and the neces-
sity for regaining the venous access in 15 (38%) 
patients and the lead-related infective endocarditis 
in the remaining 4 (6%) patients.
The procedures were performed in operating 
or hybrid-operating room equipped with a high-
quality fluoroscopy, in general anesthesia and 
with cardiac surgery standby. In pacing-dependent 
patients the femoral temporary pacing was used.
All the adhesions and sutures in the device 
pocket were surgically prepared. The step-by-step 
approach was used from less advanced to more 
aggressive: manual direct traction, device traction 
with mechanical telescopic sheaths, autorotational 
cutting sheaths and femoral approach. The manual 
direct traction (simple traction) after stylet in-
sertion was attempted for the leads, which were 
moving freely in the vessel. The most frequently 
employed technique was device traction — with 
the use of mechanical telescopic sheaths (stain-
less steel, PTFE — polytetrafluoroethylene and 
polypropylene) — Cook Vascular (Leechburg, PA, 
USA), which were rotated manually along the lead 
body to cut off the adhesions between the electrode 
and the vascular wall (Fig. 1). The locking stylet 
blocked in the intracardiac part of the lead was 
used to achieve its stiffness and to conduct a safe 
Table 1. Clinical characteristics (number of  
patients = 43).




II  20 (46.5%) 
III 6 (14%)




Arrhythmogenic RV cardiomyopathy 1 (2.3%)
Vasovagal syndrome 1 (2.3%)
Idiopathic ventricular fibrillation 2 (4.7%)
Hypertrophic cardiomyopathy 2 (4.7%)
Post-infarction HF 4 (9.3%)
HF with AV complete heart block 5 (11.6%)
Sick sinus syndrome 11 (25.6%)
AV heart block — 2nd or 3rd degree 16 (37.2%)
Type of previously implanted device:
ICD with CRT 1 (2.3%)
Dual chamber ICD 4 (9.3%)
Single chamber ICD 5 (11.7%)
Single chamber pacemaker  
— atrial or ventricular
13 (30.2%)
Dual chamber pacemaker 20 (46.5%)







*Covers system implantations, exchanges and up-grade proce-
dures; NYHA — New York Heart Association; RV — right ventricu-
lar; HF — heart failure; AV — atrioventricular; ICD — implantable 
cardioverter-defibrillator; CRT — cardiac resynchronization therapy
Figure 1. The tip-ending of the 26-year-old pacing lead 
extracted with the use of polytetrafluoroethylene tele-
scopic sheaths; the surface of the lead is covered with 
the calcified connective tissue.
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preparation of the adhesions. The anchoring of the 
stylet was possible to be performed in the majority 
of the electrodes with the preserved inner lumen.
In 2 cases the autorotational cutting sheaths 
“Evolution” — Cook Vascular (Leechburg, PA, USA) 
(Fig. 2) were used to separate the adhesions, which 
could not be overcome with polypropylene sheaths 
— the used methodology was described previously 
[1]. In 1 case the femoral approach with the Needle’s 
Eye Snare — Cook Vascular (Leechburg, PA, USA) 
was used to extract the lead, which was broken dur-
ing the attempted subclavian TLE [2].
During the procedures performed on non-
infected systems, after the lead extraction the 
guidewire was introduced to regain the venous 
access for the new implantation.
Results
The mean dwelling time was 161 months 
(median 144 months). The longest time for pacing 
and defibrillating lead was 330 and 251 months, 
respectively (Fig. 3).
The manual direct traction (simple traction) af-
ter stylet insertion was successful in 4 (6%) leads. 
The most frequently applied technique was device 
traction — with the use of mechanical telescopic 
sheaths. Clinical success was achieved in next 59 
(89%) leads. In the remaining cases the autorota-
tional cutting sheaths (2 leads; 3%) and femoral 
approach (1 lead; 1.5%) were successfully used.
Additionally, 10 leads implanted for less than 
120 months were extracted during the procedures. 
The mean number of extracted leads in 1 patient 
was 1.8 (1–4).
The intended clinical success was achieved in 
all patients. The complete procedural success rate 
was 95% (63 leads) and in the remaining 3 (5%) 
cases the small portion of the lead (< 2 cm) with 
no clinical consequence was left in the vascular 
space. The results of the procedures are presented 
in Table 2.
Fluoroscopy time was available only for last 
33 patients. Time was reached from 1 to 43 min 
(mean 16.6 min). But there was no correlation be-
tween fluoroscopy time and dwelling time (Fig. 4).
Figure 2. The example of using the “Evolution” autoro-
tational system during the extraction of the pacing lead 
from the right ventricle.
Figure 3. The number of extracted pacing and defi-
brillating leads in respective 5-year intervals from the 
implantation.
Table 2. Results of the procedures.
1. Result (l = 66)
Complete procedural success 63 l (95%)
Clinical success (< 2 cm of the lead left) 3 l (5%)
2. Finally effective techniques (l = 66)
Direct traction 4 l (6%)
Telescopic sheaths 59 l 
 (89.5%)
Evolution mechanical system* 2 l (3%)
Femoral access* 1 l (1.5%)
3. Complications (n = 43)
Major 0
Minor:
Blood loss treated with transfusion 2 pt (4.7%)
Peritoneal injury 1 pt (2.3%)
*Both methods used after attempt of telescopic sheaths extraction; 
l — leads; pt — patient; n — number of patients
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No major procedural complications, such 
as death, vascular avulsion or tear, cardiac tam-
ponade with rescue sternotomy, significant pul-
monary embolism or stroke, were observed. In 
2 cases intraprocedural blood loss was treated with 
transfusion. In 1 patient the peritoneal cavity was 
opened (2–3 cm) during the surgical preparation 
of infected tissues in the abdominal pocket (under 
the rectus abdominis muscle) of oldest implantable 
cardioverter-defibrillator system in our series. It 
was sutured with no further sequelae.
Discussion
The progress in medicine leads to the sig-
nificant prolongation of patients’ lives. It concerns 
CIEDs patients as well. Over the years they are 
referred to the scheduled device replacement and 
the upgrade of the system due to the still expand-
ing indications. Although the patients experience 
treatment-related complications, the TLE tech-
niques are more and more commonly used in deal-
ing with the complications of CIEDs therapy [3–6].
CIED-related infection is an unequivocal 
class IB indication for the total system removal. 
As the non-infectious TLE procedures are class II 
indications, the decision should always depend 
on the number of existing leads, the expected 
patient’s survival time and the prospective long- 
-term complications [7–9]. The implantation of the 
next defibrillating lead, possibly interfering with 
the previously implanted one, may result in its 
significantly shorter functioning and inappropria -
te interventions, especially in young individuals. 
It also increases the risk of vascular occlusion 
and may impede further procedures, which would 
require the central venous access [10].
Non-functional leads left in the vascular space 
increase the risk of infection as the insulation 
breakage facilitates bacterial colonization of the 
lead and inhibits the penetration of the antibiotic 
therapy [8, 11–13].
The extent of TLE procedure difficulty de-
pends much on the time passed since the lead 
implantation. In large groups of patients, including 
also those with leads older than 10 years, the com-
plication rate varies from 1% to 5%. The most seri-
ous complications, resulting in the need for surgical 
intervention or death are reported in about 2% of 
patients. We did not observe major complications 
in the study group, but patients were completely 
prepared for thoracotomy and all the procedures 
were performed in general anesthesia, with the full 
stand-by of the cardiac surgeon [9, 14–18].
We believe that one of the key elements that 
resulted in the high efficacy of TLE in the study 
group was the possibility of using different extrac-
tion devices; and the crucial effect of lead stiffen-
ing with standard or locking stylets. Similarly to 
the other centers with vast experience in TLE, 
we most often used the mechanical telescopic 
sheaths, which were manually advanced over the 
lead and provided the high efficacy and safety of 
the procedures. Furthermore, it seems that such 
device enables gentler dosage of the force needed 
for cutting off the adhesions. It is not possible in the 
mechanical systems, where this force is enhanced 
by the gear system [9, 15, 19].
The mechanical autorotating sheaths may 
be useful in the cases with massive adhesions or 
calcification, which are not always related to the 
oldest leads, but rather to the individual feature of 
the patient [1, 20, 21].
The lack of the possibility of using laser or 
electrosurgical systems in our center did not dis-
turb the achievement of the high procedural suc-
cess rate with a low complication risk [22].
It is interesting that in the group of leads im-
planted more than 10 years before the extraction, 
some of them were able to be removed with a sim-
ple direct traction. Those leads were more likely to 
be defibrillating leads, due to their stiffness and re-
sistance to extension and breaking. The percentage 
of such leads in the study group was small, whereas 
de Bie et al. [23] reported the (82%) efficacy of direct 
traction in large group of patients with electrodes 
implanted for up to 84 months [19, 24].
Figure 4. Comparison electrodes dwelling time with 
fluoroscopic time, amount of electrodes per patient fig-
ures by marker size (1 lead    , 2 to 4 leads   -   ), patients 
with implantable cardioverter-defibrillator leads marked 
with black color (  ). Correlation without statistical sig-
nificance.
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The connective tissue, which binds the leads to 
the wall of the vessel, heart or the valve apparatus, 
is not formed evenly in all patients. The quantity 
of this tissue depends on the thrombus formation 
on the lead, as well as the individual collagen type 
and calcium metabolism causing the calicification of 
the connective tissue bands. This mechanism was 
described on the basis of histological findings and 
autopsies of patients with CIEDs [25, 26].
In this study group the femoral access was 
performed in the case, where subclavian TLE 
was unsuccessful. Such approach is used in some 
centers, while the others prefer the femoral access 
as a first choice method of TLE. This way of lead 
extraction seems to be faster and of comparable 
safety. One should remember however, that the 
growing population of non-infectious patients sug-
gests performing TLE in the primary implantation 
site to regain the venous access [27, 28].
Limitations of the study
A low number of patients may be not enough 
to identify seldom complications like superior vena 
cava tear or tamponade. Lack of procedure and fluoro-
scopy time did not allow fully desired statistics.
Conclusions
Transvenous extraction of the leads which 
have been implanted in the vascular space for over 
10 years is an effective and safe method of treating 
infectious, vascular and mechanical complications 
of CIEDs therapy.
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